A retrospective evaluation of pre-bronchoscopy gargling for the prevention of bronchoscopy-related infection

Y. Mizumori (Himeji, Japan), Y. Nakahara (Himeji, Japan), R. Kominami (Himeji, Japan), K. Miyake (Himeji, Japan), H. Tsukamoto (Himeji, Japan), S. Sasaki (Himeji, Japan), T. Kawamura (Himeji, Japan)

Source: International Congress 2019 – New insights into pleural and bronchoscopic interventions
Session: New insights into pleural and bronchoscopic interventions
Session type: Poster Discussion
Number: 3398
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Mizumori (Himeji, Japan), Y. Nakahara (Himeji, Japan), R. Kominami (Himeji, Japan), K. Miyake (Himeji, Japan), H. Tsukamoto (Himeji, Japan), S. Sasaki (Himeji, Japan), T. Kawamura (Himeji, Japan). A retrospective evaluation of pre-bronchoscopy gargling for the prevention of bronchoscopy-related infection. 3398

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Efficacy of isoniazid preventive therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders-a retrospective cohort study in Taiwan
Source: International Congress 2017 – Migrants and screening
Year: 2017

Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care
Source: Eur Respir J, 56 (5) 1902246; 10.1183/13993003.02246-2019
Year: 2020



Efficacy of immunotherapy with ribomunyl in children with recurrent respiratory infections: results of 3-year prospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 338s
Year: 2002

The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Pilot study for risk assessment of aspiration pneumonia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019

Clinical assessment of oral tuberculosis – a retrospective study
Source: Annual Congress 2008 - Difficult tuberculosis cases
Year: 2008

Prospective epidemiologic study on respiratory diseases in children and immunisation against measles
Source: Eur Respir J 2003; 22: Suppl. 45, 297s
Year: 2003

Prospective comparative study on etiologic diagnosis of ventilator-associated pneumonia.
Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients
Year: 2018




Effectiveness and outcomes of air travel-related TB incident follow-up: a systematic review
Source: Eur Respir J, 57 (5) 2000013; 10.1183/13993003.00013-2020
Year: 2021



Patient-reported outcome measures in the recovery of adults hospitalised with community-acquired pneumonia: a systematic review
Source: Eur Respir J, 53 (3) 1802165; 10.1183/13993003.02165-2018
Year: 2019



Prospective evaluation of clinical and microbiological parameters in patients with community-acquired pneumonia with and without comorbidity
Source: Eur Respir J 2006; 28: Suppl. 50, 530s
Year: 2006

Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study
Source: ERJ Open Res, 4 (4) 00096-2018; 10.1183/23120541.00096-2018
Year: 2018



GRACE-01 Genomics to combat resistance against antibiotics in community-acquired LRTI in Europe – a multicentre, observational cohort study of cough/LRTI in primary care
Source: Annual Congress 2007 - Clinical trial: antibiotic use in the community
Year: 2007


Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives
Source: Eur Respir J 2004; 24: Suppl. 48, 185s
Year: 2004

Management of community-acquired pneumonia in primary care: an observational study
Source: International Congress 2019 – Treatment of airway diseases in primary care
Year: 2019


The results of a randomized clinical trial of the efficacy of the antibodies-based drug in influenza and acute respiratory viral infections in children
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019


Empiric antibiotic treatment and pathogens resistance in respiratory tract infections; a prospective epidemiological survey
Source: Eur Respir J 2003; 22: Suppl. 45, 335s
Year: 2003

Bacterial respiratory co-infections of patients hospitalized with COVID-19: a prospective microbiologic study in single tertiary hospital in Kazakhstan
Source: Virtual Congress 2021 – COVID - 19 around the globe
Year: 2021

Promising prophylactic means and methods for prevention of community-acquired pneumonia and respiratory infections among servicemen in Russia
Source: Eur Respir J 2006; 28: Suppl. 50, 350s
Year: 2006